Brenda Weigel, MD

Brenda Weigel, MSc., MD, is Vice President of Clinical Research Industry Engagment at St. Jude Children’s Research Hospital, responsible for industry engagement. She previously was the Director of the Division of Pediatric Hematology/Oncology and a Professor cross-appointed at the University of Minnesota’s Masonic Cancer Center and the Department of Pediatrics, and held the Lehman/Children's Cancer Research Fund Endowed Chair in Pediatric Cancer. She was the Co-Director of the Sarcoma Program for the Masonic Cancer Center.   

Dr. Weigel received her medical degree from McMaster University in Hamilton, Ontario, and completed her residency in pediatrics at the University of Western Ontario followed by her fellowship in Pediatric Hematology/Oncology and Bone Marrow Transplant at the University of Minnesota. 

Dr. Weigel’s major interests have been advancing new therapies for children with cancer. Her research interests are centered in her extensive involvement with the Children’s Oncology Group (COG). She Chaired the Developmental Therapeutics Committee and the NCI funded Pediatric Early Phase Trials Network from 2013-2024.  She is also active in the COGs Soft Tissue Sarcoma committee and lead trials in rhabdomyosarcoma.